LatchBio

LatchBio builds and deploys AI agents for biology, helping scientists, bioinformaticians, and computational biologists analyze experimental data. Its agent.bio sandbox lets researchers apply frontier models to sequencing data, spreadsheets, and TIFF files. Solution providers can offer customers white-labeled analysis for their kits, assays, and services. Alongside deployment, benchmarks.bio publishes reproducible evaluations of agents across single-cell biology, spatial biology, epigenomics, pharmacology, and biosecurity.

Founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, LatchBio is led by Andere as CEO. Its infrastructure work includes a developer toolkit that turns analysis scripts into interfaces and portable cloud deployments, with versioned execution and traceable data provenance. Its research extends that emphasis on reproducibility: scBench-Long tests whether agents can recover scientific conclusions from raw or near-raw single-cell data without prescribed methods, using deterministic grading of structured answers and trajectory diagnostics.

In 2026, the company reported that its deployment platform supported 40+ solution providers and 300+ biopharmas and R&D labs worldwide. That year, LatchBio acquired TwentyTwo to form Latch Biosecurity, expanding its work on safeguards for biological AI. Its historical financing includes a $28 million Series A led by Coatue and Lux Capital in 2022, following a $5 million seed round in 2021.